Trials / Terminated
TerminatedNCT00211406
Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Manhattan Eye, Ear & Throat Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control diabetic retinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anecortave Acetate Sterile Suspension (15 mg) |
Timeline
- First posted
- 2005-09-21
- Last updated
- 2007-05-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00211406. Inclusion in this directory is not an endorsement.